Constance Holden. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAnimalsAntidepressive Agents/therapeutic useBrain/physiopathologyChildClinical Trials as TopicCorticotropin-Releasing Hormone/antagonists & inhibitorsDepression/drug therapyDepression/physiopathologyDepression/therapyDepressive Disorder/drug therapyDepressive Disorder/physiopathologyDepressive Disorder/therapyDopamine Agents/therapeutic useElectric Stimulation TherapyElectroconvulsive TherapyHumansMagneticsNeurons/physiologyPhosphodiesterase Inhibitors/therapeutic usePsychotherapyReceptors, N-Methyl-D-Aspartate/antagonists & inhibitorsStress, Psychological/drug therapyStress, Psychological/physiopathologySubstance P/antagonists & inhibitors
Substances: See more » Antidepressive AgentsDopamine AgentsPhosphodiesterase InhibitorsReceptors, N-Methyl-D-AspartateSubstance PCorticotropin-Releasing Hormone
Year: 2003 PMID: 14593164 DOI: 10.1126/science.302.5646.810
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728